2017

January

The company was recognized by the Linzhi Municipal Party Committee and Municipal Government as an “Advanced Unit in Enterprise Assistance for Poverty Alleviation in Linzhi City for 2016.”

March

The company was awarded the “First Prize in the 2016 City-Wide Trade Union Work Target Responsibility Assessment” by the Lhoka City Federation of Trade Unions.

The company was awarded the honor of “Second Place in the 2016 Labor Skills Competition” by the Lhaze City Trade Union.

The company’s subsidiary, Foge Company, was awarded the title of “Advanced Unit in Trade Union Work for 2016” by the Gannan Prefecture Federation of Trade Unions.

Gansu Qizheng Tibetan Medicine Co., Ltd., a subsidiary of the company, has been awarded the title of “2016 Advanced Taxpayer Enterprise” by the Yuzhong County Party Committee and County Government.

Gansu Qizheng Tibetan Medicine Co., Ltd., a subsidiary of the company, has been awarded the honorary title of “Model Employee Family” by the Lanzhou City Federation of Trade Unions.

April

The company was awarded the honorary title of “Advanced Unit for Over-Quota Employment of Persons with Disabilities in 2016” by the Lhoka City Disabled Persons’ Federation.

June

At the Conference on the Development of the Non-Public Sector in the Tibet Autonomous Region, Qizheng Tibetan Medicine was awarded five honors in succession: Top 20 Non-Public Enterprises in 2016 by Operating Revenue; Top 20 Non-Public Enterprises in 2016 by Tax Payments; Top 20 Non-Public Enterprises in 2016 by Employment; Top 20 Non-Public Enterprises in 2016 by Innovation; and Top 20 Non-Public Enterprises in 2016 by Public Welfare and Charitable Contributions. It became the only enterprise among those attending the conference to receive all five awards.

In the 2016 assessment of information disclosure practices among the 822 listed companies on the SME Board of the Shenzhen Stock Exchange, a total of 189 companies received an A rating, and Qizheng Tibetan Medicine was among them.

August

Qizheng Pain Relief Patch was honored with the prestigious “Healthy China·Brand List” award by Zhongkang Information in 2017.

At the China Brand List Release Ceremony held in Bo'ao, Hainan, the Qizheng® brand ranked 26th on the value ranking with a valuation of 2.055 billion yuan. In the field of topical analgesics, Qizheng’s Xiao Tong Tie Gao (Pain Relief Patch) made it onto the brand list.

At the “2017 China Listed Companies Value Selection,” hosted by the Securities Times and the China Fund News, and co-organized by the Hangzhou Municipal People’s Government, our company was awarded the “11th Outstanding Secretary of the Board for China’s SME Board Listed Companies” prize.

September

Gansu Qizheng Tibetan Medicine Co., Ltd., a subsidiary of the company, has been awarded the “Gansu Province Historical and Cultural Heritage List” title.

October

At the 17th China Pharmacy Summit Forum held in Kunming, Yunnan, Qizheng Pain Relief Plaster was awarded the title of “2016-2017 China Pharmacy Top-Rated Brand for Pain Relief Plasters—Recommended by Pharmacy Staff.”

November

At the 29th National Pharmaceutical Economic Information Conference held in Changzhou, Jiangsu Province, Qizheng Tiebangchui Pain Relief Ointment was honored with a place on the “2017 China Pharmaceutical Brand List—Rui List.”

The projects “Secondary Development and Industrialization of the New Tibetan Medicine Honghua Ruyi Pill” and “Research on a Novel Drug Delivery System for Topical Treatment of Mammary Hyperplasia Using Tibetan Medicines” each received the First Prize for Scientific and Technological Innovation and Technical Invention, awarded by the China Association of Ethnic Medicine.

The company has received the “Science and Technology Award” certificate issued by the Chinese Association of Traditional Chinese Medicine.

December

Qizheng Pain Relief Patch has been awarded the “Top 10 OTC Outstanding Innovation Award” by the Over-the-Counter Drug Association.

Gansu Qizheng Tibetan Medicine Co., Ltd., a subsidiary of the company, has been awarded the honorific title of “National Intellectual Property Demonstration Enterprise and Leading Enterprise for 2017,” making it one of the 103 companies in the pharmaceutical industry to receive this recognition.

At the 10th International Symposium on Corporate Social Responsibility Reports of Chinese Enterprises, the company’s 2016 Corporate Social Responsibility Report stood out from among 1,433 publicly released CSR reports and was awarded the “Golden Bee 2017 Outstanding CSR Report—Growth Enterprise Award,” becoming one of the 73 winning enterprises.